Goldman Sachs on Vera Therapeutics (VERA): 'We are encouraged by today's update'
Tweet Send to a Friend
Goldman Sachs analyst Paul Choi reiterated a Buy rating and $90.00 price target on Vera Therapeutics (NASDAQ: VERA).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
